Evidence of the direct effect of ghrelin on AD-like pathology was first documented in the Senescence-Accelerated Mouse Prone 8 (SAMP8) model, widely used to examine the pathology of early AD defects (Diano et al. 2006; Pacesova et al. 2022). This evidence concerns the gene GHRL and Alzheimer disease.